Little joys for everyday · Free shipping over $75
Login Register
altimmune glp-1 hits NASH target in phase 1 trial What is the pipeline for
altimmune glp-1 hits NASH target in phase 1 trial What is the pipeline for
altimmune glp-1 hits NASH target in phase 1 trial What is the pipeline for
altimmune glp-1 hits NASH target in phase 1 trial What is the pipeline for
altimmune glp-1

altimmune glp-1 hits NASH target in phase 1 trial What is the pipeline for

SKU: 288098295

4.7
EUR23.10 EUR70.10

Pay in 4 interest-free payments of $5.78 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

doi: 10.1210/clinem/dgaa863 190 LeeCJMaoHThieuVTLandLFThomasMK

altimmune glp-1 hits NASH target in phase 1 trial What is the pipeline for

In animal studies, AOD-9604 reduced body weight gain by over 50% in obese mice during a 19-day treatment period, and significantly increased fat oxidation all without affecting insulin sensitivity or glucose regulation.[1,3] A randomized controlled trial in humans found that participants taking 1 mg of AOD-9604 daily lost an average of 2.8 kg (~6 lbs) over 23 weeks, compared to 0.8 kg (~1.7 lbs) in the placebo group

altimmune glp-1 hits NASH target in phase 1 trial What is the pipeline for

Why these four peptides together

altimmune glp-1 hits NASH target in phase 1 trial What is the pipeline for

Immunopharmacol 6, 587592

altimmune glp-1 hits NASH target in phase 1 trial What is the pipeline for

Ik ben er ontzettend blij mee

altimmune glp-1 hits NASH target in phase 1 trial What is the pipeline for
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products